Envista Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Envista Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-27 | 2025-03-28 | 2024-12-31 | 2024-09-27 | 2024-06-28 | 2024-03-29 | 2023-12-31 | 2023-09-29 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-07-01 | 2022-04-01 | 2021-12-31 | 2021-10-01 | 2021-07-02 | 2021-04-02 | 2020-12-31 | 2020-10-02 | 2020-07-03 | 2020-04-03 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||||||||
net income | 26,400,000 | 18,000,000 | 1,200,000 | 8,200,000 | -1,151,600,000 | 23,600,000 | -217,400,000 | 21,500,000 | 51,900,000 | 43,800,000 | 73,500,000 | 47,600,000 | 47,100,000 | 74,900,000 | 85,800,000 | 92,900,000 | 90,100,000 | 71,700,000 | 108,400,000 | 35,600,000 | -93,500,000 | -17,200,000 |
noncash items: | ||||||||||||||||||||||
depreciation | 10,800,000 | 9,100,000 | 9,200,000 | 10,500,000 | 11,600,000 | 9,500,000 | 9,200,000 | 8,900,000 | 9,400,000 | 8,500,000 | 7,900,000 | 7,800,000 | 8,300,000 | 7,800,000 | 11,400,000 | 9,500,000 | 9,600,000 | 10,300,000 | 10,900,000 | 11,900,000 | 10,100,000 | 9,500,000 |
amortization | 19,000,000 | 18,800,000 | 18,600,000 | 18,700,000 | 22,400,000 | 22,600,000 | 23,700,000 | 23,900,000 | 24,100,000 | 27,900,000 | 27,800,000 | 27,900,000 | 26,800,000 | 23,500,000 | 20,200,000 | 20,600,000 | 21,000,000 | 21,000,000 | 22,200,000 | 22,700,000 | 22,800,000 | 22,500,000 |
allowance for credit losses | 2,700,000 | 1,300,000 | 1,900,000 | 2,200,000 | 9,300,000 | 4,500,000 | 3,600,000 | 300,000 | 1,200,000 | 2,000,000 | 1,000,000 | 200,000 | 1,900,000 | 1,700,000 | 1,400,000 | 600,000 | 700,000 | 2,900,000 | ||||
stock-based compensation expense | 9,700,000 | 7,100,000 | 9,200,000 | 9,800,000 | 5,300,000 | 11,000,000 | 4,500,000 | 6,000,000 | 5,200,000 | 15,000,000 | 7,400,000 | 7,300,000 | 8,300,000 | 7,500,000 | 6,600,000 | 7,300,000 | 7,900,000 | 6,400,000 | 5,900,000 | 5,000,000 | 5,700,000 | 6,000,000 |
gain on investments in rabbi trust | ||||||||||||||||||||||
loss on equity investments | ||||||||||||||||||||||
loss on sale of property, plant and equipment | ||||||||||||||||||||||
restructuring charges | 0 | 200,000 | -200,000 | 600,000 | -100,000 | 700,000 | 100,000 | -800,000 | 1,700,000 | 5,700,000 | -1,900,000 | 10,500,000 | 0 | 0 | 2,100,000 | |||||||
goodwill and intangible asset impairments | 0 | 0 | ||||||||||||||||||||
fixed assets impairments and other charges | 0 | 0 | ||||||||||||||||||||
non-cash operating lease costs | 8,800,000 | 8,400,000 | 8,300,000 | 8,100,000 | ||||||||||||||||||
amortization of debt discount and issuance costs | 1,100,000 | 1,100,000 | 1,200,000 | 1,400,000 | 1,100,000 | 1,200,000 | 1,200,000 | 1,300,000 | 1,100,000 | 1,000,000 | 1,100,000 | 1,000,000 | 1,000,000 | 1,000,000 | 5,700,000 | 5,600,000 | 5,800,000 | 6,200,000 | 5,400,000 | 5,300,000 | ||
deferred income taxes | 17,800,000 | -700,000 | ||||||||||||||||||||
change in trade accounts receivable | -15,900,000 | -21,300,000 | 10,900,000 | -6,000,000 | 21,400,000 | -16,300,000 | 16,000,000 | -9,000,000 | -15,500,000 | -8,500,000 | 5,500,000 | -19,900,000 | -40,400,000 | -16,200,000 | -28,100,000 | -13,600,000 | 3,600,000 | -5,100,000 | 7,600,000 | -61,800,000 | 53,100,000 | 73,000,000 |
change in inventories | -13,400,000 | -10,100,000 | 15,200,000 | -600,000 | 1,200,000 | -12,200,000 | 25,700,000 | 13,300,000 | 3,200,000 | -7,100,000 | -4,000,000 | -6,400,000 | -9,200,000 | -20,300,000 | 1,100,000 | -19,200,000 | -27,500,000 | -20,400,000 | -4,900,000 | 26,200,000 | 27,300,000 | -36,700,000 |
change in trade accounts payable | 5,100,000 | -15,100,000 | 6,300,000 | -2,500,000 | -2,300,000 | -2,700,000 | 6,900,000 | -6,100,000 | -9,000,000 | -38,100,000 | 33,200,000 | 5,400,000 | 8,400,000 | -2,500,000 | 19,600,000 | -16,400,000 | 4,100,000 | -27,600,000 | 70,900,000 | 27,800,000 | -66,400,000 | -10,700,000 |
change in prepaid expenses and other assets | 3,500,000 | -7,800,000 | 6,200,000 | -9,200,000 | 100,000 | -3,800,000 | -2,100,000 | 6,500,000 | -2,400,000 | 1,300,000 | 10,000,000 | -4,300,000 | -600,000 | -16,800,000 | 11,900,000 | -16,200,000 | 700,000 | -7,900,000 | 31,300,000 | -30,800,000 | -14,400,000 | 11,400,000 |
change in accrued expenses and other liabilities | 43,700,000 | 800,000 | 35,000,000 | 42,800,000 | 52,400,000 | 4,300,000 | 14,100,000 | 1,100,000 | 14,100,000 | -41,300,000 | -23,300,000 | -28,800,000 | -29,400,000 | -51,500,000 | 53,000,000 | 15,500,000 | 3,700,000 | -37,900,000 | 10,800,000 | 90,000,000 | 28,000,000 | -118,800,000 |
change in operating lease liabilities | -11,400,000 | -10,800,000 | -11,300,000 | -11,400,000 | -10,800,000 | -9,300,000 | -8,900,000 | -8,800,000 | -8,500,000 | -8,300,000 | -8,200,000 | -7,900,000 | -7,500,000 | -8,000,000 | -8,400,000 | -8,400,000 | -8,600,000 | -12,100,000 | -9,500,000 | -9,100,000 | -9,000,000 | -9,100,000 |
net cash from operating activities | 88,700,000 | 300,000 | 132,400,000 | 70,700,000 | 93,100,000 | 40,300,000 | 102,000,000 | 95,500,000 | 75,100,000 | 3,100,000 | 110,300,000 | 46,700,000 | 22,200,000 | 3,500,000 | 136,000,000 | 88,300,000 | 120,700,000 | 16,600,000 | 193,400,000 | 148,100,000 | 4,700,000 | -62,300,000 |
cash flows from investing activities: | ||||||||||||||||||||||
payments for additions to property, plant and equipment | -12,300,000 | -5,900,000 | -8,600,000 | -7,400,000 | -6,800,000 | -11,000,000 | -8,200,000 | -18,400,000 | -14,100,000 | -17,500,000 | -16,900,000 | -26,900,000 | -12,100,000 | -19,800,000 | -8,700,000 | -17,500,000 | -20,200,000 | -8,300,000 | -13,100,000 | -13,200,000 | -7,800,000 | -13,600,000 |
purchases of investments held in rabbi trust | -300,000 | -700,000 | -200,000 | |||||||||||||||||||
proceeds from sale of investments held in rabbi trust | 200,000 | 700,000 | 500,000 | |||||||||||||||||||
proceeds from sales of property, plant and equipment | 0 | 500,000 | 1,700,000 | 0 | ||||||||||||||||||
all other investing activities | -4,700,000 | -3,400,000 | -1,700,000 | 600,000 | 500,000 | 300,000 | -11,000,000 | -7,700,000 | 600,000 | -4,500,000 | -100,000 | -4,900,000 | -8,500,000 | -5,100,000 | -13,100,000 | 2,800,000 | 2,900,000 | 2,800,000 | 2,700,000 | 3,600,000 | 3,900,000 | 3,800,000 |
net cash from investing activities | -17,100,000 | -8,800,000 | -7,400,000 | -30,600,000 | -5,900,000 | -10,700,000 | -12,600,000 | -25,000,000 | -2,800,000 | -22,000,000 | -1,100,000 | -69,700,000 | -591,600,000 | 5,100,000 | -3,100,000 | -17,300,000 | -5,500,000 | -5,100,000 | -9,600,000 | -3,000,000 | -51,400,000 | |
cash flows from financing activities: | ||||||||||||||||||||||
proceeds from stock option exercises | 700,000 | 800,000 | 400,000 | 100,000 | 600,000 | 1,300,000 | 3,800,000 | 1,600,000 | 1,300,000 | 4,600,000 | 1,900,000 | 4,500,000 | 2,300,000 | 13,100,000 | 3,500,000 | 2,200,000 | 8,500,000 | 5,300,000 | 5,100,000 | 3,700,000 | 1,700,000 | 3,300,000 |
cash paid for treasury stock | -85,700,000 | -14,600,000 | ||||||||||||||||||||
tax withholding payment related to net settlement of equity awards | -500,000 | -3,800,000 | -1,300,000 | -600,000 | -100,000 | -3,300,000 | -100,000 | -1,400,000 | -300,000 | -6,100,000 | -200,000 | -800,000 | -500,000 | -7,600,000 | ||||||||
repayment of convertible notes due 2025 | ||||||||||||||||||||||
proceeds from revolving line of credit | 0 | 0 | 0 | |||||||||||||||||||
all other financing activities | 0 | 0 | -200,000 | -600,000 | -100,000 | -1,400,000 | -1,700,000 | -6,400,000 | 0 | 1,000,000 | -1,300,000 | 1,700,000 | -6,600,000 | 5,500,000 | ||||||||
net cash from financing activities | -86,400,000 | -17,600,000 | -900,000 | -100,500,000 | 300,000 | -2,600,000 | 3,300,000 | 114,500,000 | 2,600,000 | -1,500,000 | -68,300,000 | 73,700,000 | 1,800,000 | 5,300,000 | 1,800,000 | -4,300,000 | 6,500,000 | -469,600,000 | 258,500,000 | |||
effect of exchange rate changes on cash and cash equivalents | 48,100,000 | 34,300,000 | -46,300,000 | 15,500,000 | 200,000 | -18,500,000 | 23,100,000 | -12,500,000 | -8,400,000 | -1,300,000 | -2,500,000 | -5,300,000 | 12,400,000 | -9,200,000 | 8,400,000 | 4,000,000 | ||||||
net change in cash and cash equivalents | 33,300,000 | 8,200,000 | 77,800,000 | -44,900,000 | 87,700,000 | 8,500,000 | 115,800,000 | 172,500,000 | 66,500,000 | -21,700,000 | 38,400,000 | 45,400,000 | -555,200,000 | 4,700,000 | 434,800,000 | 84,900,000 | ||||||
beginning balance of cash and cash equivalents | 0 | 1,069,100,000 | 0 | 0 | 0 | 940,000,000 | 0 | 0 | 0 | 606,900,000 | 0 | 0 | 0 | 1,073,600,000 | 0 | 0 | ||||||
ending balance of cash and cash equivalents | 33,300,000 | 1,077,300,000 | 77,800,000 | -44,900,000 | 87,700,000 | 948,500,000 | 115,800,000 | 172,500,000 | 66,500,000 | 585,200,000 | 38,400,000 | 45,400,000 | -555,200,000 | 1,078,300,000 | 434,800,000 | 84,900,000 | ||||||
supplemental data: | ||||||||||||||||||||||
cash paid for interest | 9,700,000 | 13,400,000 | 9,300,000 | 15,900,000 | 12,800,000 | 16,700,000 | 15,300,000 | 12,600,000 | 21,000,000 | 14,300,000 | 17,300,000 | 7,300,000 | 11,000,000 | 2,800,000 | 11,600,000 | 10,500,000 | 22,400,000 | 17,500,000 | 13,900,000 | 2,900,000 | ||
cash paid for taxes | 16,400,000 | 5,200,000 | 3,100,000 | 13,900,000 | 12,100,000 | 3,800,000 | 49,100,000 | 16,000,000 | 26,900,000 | 6,600,000 | 39,000,000 | 14,100,000 | 45,400,000 | 5,700,000 | 6,300,000 | 8,100,000 | 3,600,000 | 10,600,000 | ||||
rou assets obtained in exchange for operating lease obligations | 7,800,000 | 1,200,000 | 10,300,000 | 25,000,000 | 8,000,000 | 11,500,000 | 3,200,000 | 6,800,000 | 4,500,000 | 7,600,000 | 6,400,000 | 7,100,000 | 8,200,000 | 2,600,000 | 12,100,000 | 11,700,000 | 3,500,000 | 800,000 | ||||
loss on investments in rabbi trust | 600,000 | |||||||||||||||||||||
treasury stock purchases in accrued liabilities | 4,300,000 | |||||||||||||||||||||
gain on equity investments | -100,000 | -600,000 | 0 | |||||||||||||||||||
gain on sale of property, plant and equipment | -3,400,000 | -800,000 | 0 | 0 | ||||||||||||||||||
gain on sale of kavo treatment unit and instrument business | 0 | 0 | -2,900,000 | -6,000,000 | ||||||||||||||||||
fair value adjustment of acquisition-related inventory | ||||||||||||||||||||||
inducement expense related to exchange of convertible notes | 0 | |||||||||||||||||||||
proceeds from sale of equity investment | 0 | 0 | 0 | 0 | ||||||||||||||||||
acquisitions, net of cash acquired | 0 | 0 | 900,000 | -41,600,000 | ||||||||||||||||||
proceeds from sale of kavo treatment unit and instrument business | 14,100,000 | 31,000,000 | -1,200,000 | 30,000,000 | ||||||||||||||||||
proceeds from the settlement of derivative financial instruments | 500,000 | 100,000 | ||||||||||||||||||||
proceeds from issuance of convertible notes due 2028 | 0 | |||||||||||||||||||||
debt issuance costs related to issuance of convertible notes due 2028 | -300,000 | |||||||||||||||||||||
principal paid related to exchange of convertible notes due 2025 | 0 | |||||||||||||||||||||
proceeds from borrowings | 0 | 0 | 300,000 | 249,800,000 | ||||||||||||||||||
repayment of borrowings | 0 | 0 | 0 | -500,000 | 0 | -100,000 | -100,000 | -475,500,000 | 0 | -100,000 | ||||||||||||
debt issuance costs related to other borrowings | 0 | |||||||||||||||||||||
repayment of revolving line of credit | -70,000,000 | 0 | ||||||||||||||||||||
impairment charges | 800,000 | 100,000 | -100,000 | 300,000 | 600,000 | 900,000 | 1,000,000 | 3,900,000 | 9,000,000 | 5,300,000 | 2,200,000 | 1,900,000 | 15,500,000 | 6,800,000 | ||||||||
amortization of right-of-use assets | 7,300,000 | 7,100,000 | 6,800,000 | 6,600,000 | 6,500,000 | 6,600,000 | 6,500,000 | 4,800,000 | 6,400,000 | 7,000,000 | 7,000,000 | 7,100,000 | 7,200,000 | 7,400,000 | 7,900,000 | 7,400,000 | 7,800,000 | |||||
other impairment charges | ||||||||||||||||||||||
change in deferred income taxes | ||||||||||||||||||||||
gain on sale of equity investment | ||||||||||||||||||||||
proceeds from borrowing | 0 | |||||||||||||||||||||
repayment of borrowing | 0 | |||||||||||||||||||||
proceeds from issuance of convertible senior notes | 0 | 0 | ||||||||||||||||||||
payment of debt issuance and other deferred financing costs | 0 | 0 | -1,900,000 | -400,000 | 0 | 100,000 | ||||||||||||||||
purchase of capped calls related to issuance of convertible senior notes | 0 | 0 | ||||||||||||||||||||
fair value of acquisition-related inventory | ||||||||||||||||||||||
acquisition, net of cash acquired | -126,400,000 | |||||||||||||||||||||
net cash from (used) in investing activities | ||||||||||||||||||||||
proceeds from the public offering of common stock, net of issuance costs | ||||||||||||||||||||||
consideration to former parent in connection with the separation | ||||||||||||||||||||||
net transfers to former parent | ||||||||||||||||||||||
effect of exchange rate changes on cash and equivalents | 10,800,000 | -4,000,000 | -15,700,000 | -7,500,000 | -2,400,000 | |||||||||||||||||
net change in cash and equivalents | -447,700,000 | 188,100,000 | -121,600,000 | 468,800,000 | 142,400,000 | |||||||||||||||||
beginning balance of cash and equivalents | 888,900,000 | 0 | 0 | 0 | 211,200,000 | |||||||||||||||||
ending balance of cash and equivalents | 441,200,000 | 188,100,000 | -121,600,000 | 468,800,000 | 353,600,000 | |||||||||||||||||
assets acquired: | ||||||||||||||||||||||
cash | 2,900,000 | 0 | 2,900,000 | |||||||||||||||||||
trade accounts receivable | 1,000,000 | 0 | 1,000,000 | |||||||||||||||||||
inventories | 1,900,000 | 0 | 1,900,000 | |||||||||||||||||||
prepaid expenses and other current assets | 200,000 | 0 | 200,000 | |||||||||||||||||||
property, plant and equipment | 500,000 | 0 | 500,000 | |||||||||||||||||||
goodwill | 25,100,000 | -800,000 | 25,200,000 | |||||||||||||||||||
other intangible assets | 22,300,000 | 0 | 22,300,000 | |||||||||||||||||||
total assets acquired | 53,900,000 | -800,000 | 54,000,000 | |||||||||||||||||||
liabilities assumed: | ||||||||||||||||||||||
trade accounts payable | -100,000 | 0 | -100,000 | |||||||||||||||||||
accrued expenses and other liabilities | -10,200,000 | 0 | -9,400,000 | |||||||||||||||||||
total liabilities assumed | -10,300,000 | 0 | -9,500,000 | |||||||||||||||||||
total net assets acquired | 43,600,000 | -800,000 | 44,500,000 | |||||||||||||||||||
allowance for doubtful accounts | 8,500,000 | |||||||||||||||||||||
consideration to danaher in connection with the separation | ||||||||||||||||||||||
net cash from in financing activities | ||||||||||||||||||||||
net cash from (used) in financing activities | ||||||||||||||||||||||
net transfers from former parent | ||||||||||||||||||||||
restructuring and impairment charges | ||||||||||||||||||||||
proceeds from borrowings, net of deferred costs | ||||||||||||||||||||||
payment for purchase of noncontrolling interest and related transactions | ||||||||||||||||||||||
category | ||||||||||||||||||||||
buildings | ||||||||||||||||||||||
leased assets and leasehold improvements | ||||||||||||||||||||||
machinery and equipment | ||||||||||||||||||||||
net earnings | ||||||||||||||||||||||
net proceeds from borrowings | ||||||||||||||||||||||
net transfers to parent | ||||||||||||||||||||||
supplemental disclosures: | ||||||||||||||||||||||
cash income tax payments | ||||||||||||||||||||||
cash interest payments |
We provide you with 20 years of cash flow statements for Envista stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Envista stock. Explore the full financial landscape of Envista stock with our expertly curated income statements.
The information provided in this report about Envista stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.